Novartis AG (NVS) Stock: Revenue, Earnings, Margins & Valuation

Novartis AG (NVS), Switzerland at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.

Novartis AG key figures (FY 2025)

Novartis AG revenue by segment (FY 2025)

Novartis AG earnings analysis

In the latest reported fiscal year (FY 2025), Novartis AG generated revenue of 54.53 USD bn. The largest segment is United States with 23.33 USD bn, about 42.8 % of total segment revenue. From gross margin (87.9 %) through operating margin (32.3 %) to net margin (25.6 %), the Sankey diagram shows how much of each revenue dollar remains at each stage of the income statement.

Novartis AG business model

The income statement of Novartis AG is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.

More stock analyses like Novartis AG

• Roche Holding AG stock (RHHBY)
• NextEra Energy Inc. stock (NEE)
• Novo Nordisk A/S stock (NVO)
• Netflix Inc. stock (NFLX)
• NVIDIA Corporation stock (NVDA)
• Nestlé S.A. stock (NESN.SW)
• Oracle Corporation stock (ORCL)
• Morgan Stanley stock (MS)
• Palantir Technologies stock (PLTR)
• Mitsubishi UFJ Financial Group stock (MUFG)

Novartis AG in detail

• Novartis AG valuation: P/E, price and risk
• Novartis AG earnings: quarterly revenue and EPS